Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Welcome, everybody. My name is Chris Shibutani. I'm the newest member of the Goldman Sachs Biotech Equity Research team. Thank you for joining us for our 42nd Annual Healthcare Conference, virtual, hopefully, the last time we'd do a virtual one. Very happy to have joining us, Kevin Gorman, CEO of Neurocrine Biosciences. Kevin, thanks for joining us today.
Thank you for the opportunity, Chris, and thanks to Goldman Sachs also. And I'm with you. I do hope this is the last virtual time around. I much more enjoyed being in person with everyone.
Questions & Answers
Terrific. Yes. No. And I love that you're at your desk, coffee cup, the whole backdrop there. This is total workshop, Kevin, which I think a lot of people who know you. There's no fuss, no muss. Sleeves are -- sleeves should
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
